Stock Screener - US Stocks, Forex and ETFs Please enable JavaScript to view this page content properly  
     
   MACD(12,26,9) Above Zero     
Criteria:
MACD(12,26,9) Above Zero
  Back to MACD Stock Screener
           
   Symbol   Name   Industry   Sector   Exchange  Cap, mln  Last  Change  Change, %  Volume
 A    Agilent Technologies Inc  Medical Laboratories & Research Healthcare NYSE 19,213  62.77  -0.19 -0.3 1,441,633
 AA    Alcoa Corp  Aluminum Basic Materials NYSE 7,230  41.06  1.29 3.2 4,820,758
 AAAP    Advanced Accelerator Applications SA  Pharmaceuticals Healthcare NASDAQ 2,180  48.59  -0.06 -0.1 24,010
 AAC    AAC Holdings Inc  Specialized Health Services Healthcare NYSE 211  8.93  -0.19 -2.1 48,701
 AADR    AdvisorShares Dorsey Wright ADR ETF  Exchange Traded Fund Financial NYSE   51.84  0.07 0.1 54,063
 AAN    Aaron`s Inc  Rental & Leasing Services Services NYSE 3,183  43.51  -0.61 -1.4 748,462
 AAPC    Atlantic Alliance Partnership Corp  Conglomerates Conglomerates NASDAQ 39  10.60  0.38 3.7 0
 AAPL    Apple Inc  Electronic Equipment Consumer Goods NASDAQ 813,520  159.98  0.20 0.1 19,284,372
 AAT    American Assets Trust Inc  REIT - Retail Financial NYSE 1,918  40.16  0.23 0.6 173,426
 AAWW    Atlas Air Worldwide Holdings Inc  Air Services, Other Services NASDAQ 1,570  63.10  -0.60 -0.9 240,754
Please sign up for viewing the full list of stocks


Education MACD - Technical Analysis from A to Z
The MACD (Moving Average Convergence/Divergence) is a trend following momentum indicator that shows the relationship between two moving averages of prices. The MACD is the difference between a 26-day and 12-day exponential moving average. A 9-day exponential moving average, called the "signal" line is plotted on top of the MACD to show buy/sell opportunities. The MACD proves most effective in wide-swinging trading markets. There are three popular ways to use the MACD: crossovers, overbought/oversold conditions, and divergences. Learn more




Disclaimer - FAQ - Contact Us
Copyright ©2008-2017 Market In&Out. All rights reserved.
Best viewed in